Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$31K
-31.1% from 2023
Prescriptions
23
$1,349.01 per claim
Patients
-
5 prescribers
Total spending, 2024
$31K
- per patient
Medicare prescription drug plans paid $31K for Flexbumin in 2024, for 23 prescriptions and refills to - patients (down 31.1% from 2023). The average cost per claim was $1,349.01.
New York had the highest Medicare cost for Flexbumin in 2024: $30K for 18 claims.
Arye Rubinstein, allergy/ immunology in Bronx, NY, had the highest Medicare cost for Flexbumin in 2024: 18 claims costing $30K.
Flexbumin is made by Takeda Pharmaceutical Company Limited (TAK), listed in the Medicare spending data as Takeda Pharmace.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Arye Rubinstein Bronx, NY | Allergy/ Immunology | 18 | Under 11 | $30K |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 5 | 22 | - | $34K |
| 2023 | 2 | 28 | - | $45K |
| 2024 | 5 | 23 | - | $31K |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Manufacturer | Claims | Spending |
|---|---|---|
| Takeda Pharmace TAK | 23 | $31K |